Datwyler, LTS Device Technologies, and Stevanato Group Collaborate to Expand Self-Delivery Options for Large-Volume Drugs
Stevanato Group S.p.A. Ordinary Shares (STVN)
Company Research
Source: PR Newswire
Enables convenient on-body delivery of higher dose therapies like anti-cancer treatments and monoclonal antibodiesUtilizes a pre-verified large-volume platform solution to speed time to marketMeets evolving industry needs amid shift from hospital to home administrationPARIS, Jan. 16, 2026 /PRNewswire/ -- Datwyler (Middletown, Delaware) a leading provider of high-value, system-critical elastomer components, announced a collaboration with LTS Device Technologies, a developer of smart wearable devices for drug delivery, and Stevanato Group (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions.Together the companies aim to broaden the scope of large-volume subcutaneous drug delivery by enabling convenient on-body administration of larger volumes – meeting the evolving needs of patients, alongside market demands. The three companies will unveil their platform solution at a joint Learning Lab presentation: When Size Matters: The Evolution of Se
Show less
Read more
Impact Snapshot
Event Time:
STVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STVN alerts
High impacting Stevanato Group S.p.A. Ordinary Shares news events
Weekly update
A roundup of the hottest topics
STVN
News
- Stevanato Group (STVN) was downgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "hold (c-)" to "sell (d+)".MarketBeat
- Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum [Yahoo! Finance]Yahoo! Finance
- Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare ForumBusiness Wire
- Stevanato Group (STVN) had its price target lowered by Morgan Stanley from $24.00 to $19.00. They now have an "equal weight" rating on the stock.MarketBeat
- Stevanato: Strong Q4 Results Reinforce Long-Term Growth Story [Seeking Alpha]Seeking Alpha
STVN
Earnings
- 3/4/26 - Miss
STVN
Sec Filings
- 3/25/26 - Form 3
- 3/25/26 - Form 3
- 3/18/26 - Form 3
- STVN's page on the SEC website